Skip to content

Zoetis ZTS Price / earnings

Price / earnings at other companies

Merck & Co. logo
Merck & Co.MRK
33.3×+20.3×
Idexx Laboratories logo
Idexx LaboratoriesIDXX
40.7×+2.7×
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
227.4×+192×
Revvity logo
RevvityRVTY
40.9×-3.5×
Tractor Supply Company logo
Tractor Supply CompanyTSCO
12.2×-14.8×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
26.7×-2.2×

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$33B-32.3%
Enterprise value$41.04B-26.4%
P/S3.5×-1.8×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Calculated from Zoetis’s reported figures.

Based on the most recent quarter.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's price / earnings?
Zoetis (ZTS) reported price / earnings of 18.9× in Q1 2026.
How has Zoetis's price / earnings changed year-over-year?
Zoetis's price / earnings decreased by 36.3% year-over-year, from 29.6× to 18.9×.
What is the long-term trend for Zoetis's price / earnings?
Over 5 years (2020 to 2025), Zoetis's price / earnings has grown at a -15.2% compound annual growth rate (CAGR), from 47.8× to 21×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.